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The synaptosome-associated protein of 25 kDa (SNAP-
25) interacts with syntaxin 1 and vesicle-associated
membrane protein 2 (VAMP2) to form a ternary soluble
N-ethylmaleimide-sensitive fusion protein attachment
protein receptor (SNARE) complex that is essential for
synaptic vesicle exocytosis. We report a novel RING fin-
ger protein, Spring, that specifically interacts with
SNAP-25. Spring is exclusively expressed in brain and is
concentrated at synapses. The association of Spring
with SNAP-25 abolishes the ability of SNAP-25 to inter-
act with syntaxin 1 and VAMP2 and prevents the assem-
bly of the SNARE complex. Overexpression of Spring or
its SNAP-25-interacting domain reduces Ca2-depend-
ent exocytosis from PC12 cells. These results indicate
that Spring may act as a regulator of synaptic vesicle
exocytosis by controlling the availability of SNAP-25 for
the SNARE complex formation.
superhelical structure by various mutations in the SNAREs
has been shown to inhibit membrane fusion (5, 6). Moreover,
specific cleavage of each SNARE by the clostridial neurotoxins
prevents the assembly of a stable SNARE complex and blocks
neurotransmitter release without affecting the docking of syn-
aptic vesicles (7, 8). Thus, the formation of the SNARE complex
is a crucial event in the synaptic vesicle fusion process.
Although the functional importance of the SNARE complex
in membrane fusion is well established, its precise role in the
fusion process remains unclear. It has been proposed that the
formation of the SNARE complex in a trans configuration pulls
the apposing membranes into close contact and provides a
driving force for membrane fusion (9). Consistent with this
view, the assembly of SNARE complexes has been shown to
serve as the minimal machinery for membrane fusion in recon-
stituted liposomes (10). Furthermore, the SNARE complex for-
mation in permeabilized PC12 cells is triggered by Ca2 and
coupled directly to exocytosis (11). On the other hand, evidence
from studies of yeast vacuole fusion suggests that the SNARE
complex does not act at the fusion step (12). Rather, the com-
plex formation occurs at an upstream step to signal other
proteins to execute fusion (13). In addition, a recent study using
synaptosomes suggests that SNARE complexes assemble at the
priming step prior to neurotransmitter release and may regu-
late the amount of synaptic vesicle to undergo exocytosis (14).
Whereas the SNAREs and the SNARE complex seem to be
universally required for all fusion reactions, synaptic vesicle
exocytosis is several orders of magnitude faster and more
tightly regulated than any other form of membrane fusion (15).
To achieve the extraordinary speed, precision, and plasticity of
neurotransmission, additional proteins have to be involved to
regulate the function of these SNAREs and control temporal
and spatial formation of SNARE complexes. In an effort to
identify additional proteins that regulate neurotransmitter re-
lease, we have performed a search in rat brain for SNAP-25-
binding proteins using a yeast two-hybrid screen. We report
here the isolation of a novel RING finger protein, termed
Spring, that specifically interacts with SNAP-25 and modu-
lates the SNARE complex formation and Ca2-dependent
exocytosis.
EXPERIMENTAL PROCEDURES
Identification and cDNA Cloning of Spring—Yeast two-hybrid
screens to identify novel SNAP-25-interacting proteins were performed
as described previously (16). Prey plasmids from positive clones were
rescued and re-transformed into fresh yeast cells with the pPC97-
SNAP-25 bait or various control baits to confirm the specificity of the
interactions. For cloning of full-length Spring, a partial Spring cDNA
probe from the prey clone was used to screen a rat hippocampal cDNA
library in ZAPII (Stratagene), according to standard procedures (17).
The cDNA inserts from positive Spring clones were sequenced multiple
times on both strands by an Applied Biosystems 373A DNA sequencer.
Antibodies—A polyclonal anti-Spring antibody was raised in rabbit
against amino acid residues 138–151 (DDRGLRGFPKNRVL) of Spring.
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At synapses, neurotransmitters are released via Ca2-trig-
gered exocytotic fusion of synaptic vesicles with the presynap-
tic plasma membrane. Recent genetic and biochemical studies 
have revealed that this highly regulated fusion process in-
volves a cascade of protein-protein and protein-lipid interac-
tions (1, 2). Among them, a ternary protein complex known as 
the soluble N-ethylmaleimide-sensitive fusion protein attach-
ment protein receptor (SNARE)1 complex is of fundamental 
importance for synaptic vesicle exocytosis (3). The SNARE 
complex is assembled by three neuronal SNAREs, vesicle-as-
sociated membrane protein 2 (VAMP2, also called synaptobre-
vin), and presynaptic plasma membrane proteins syntaxin 1 
and synaptosome-associated protein of 25 kDa (SNAP-25). 
Structural studies have demonstrated that the SNARE com-
plex consists of a parallel four-stranded helical bundle formed 
by two helices from SNAP-25 and one helix each from VAMP2 
and syntaxin 1 (4). Interference with the integrity of such a 
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The antibody was affinity-purified using the immunogen peptide cou-
pled to an Aminolink Immobilization column (Pierce). Other antibodies
used in this study are as follows: anti-SNAP-25 (SMI 81, Sternberger
Monoclonals, Inc.); anti-syntaxin 1 (HPC-1, Sigma); anti-VAMP2 (Wako
Pure Chemical Industries, Ltd.); anti-synaptophysin (SVP-38, Sigma);
and anti-HA (3F10, Roche Molecular Biochemicals).
Northern and Western Blot Analyses—Northern blot analysis of
Spring mRNA expression was performed on a rat Multiple Tissue
Northern (MTNTM) blot and a human Multiple Tissue Expression
(MTETM) Array (CLONTECH), using a 32P-labeled Spring cDNA frag-
ment from the prey clone as probe (17). For Western blot analysis, rat
tissues were homogenized in 1% SDS and subjected to SDS-PAGE. The
proteins were transferred onto nitrocellulose membranes and probed
with anti-Spring and other antibodies. Horseradish peroxidase-conju-
gated secondary antibodies and enhanced chemiluminescence were
used to visualize the results.
Expression Constructs—Conventional molecular biological tech-
niques (17) were used to generate the constructs in this study. DNA
fragments encoding full-length and truncated forms of Spring were
subcloned into the following vectors: the pPC97 and pPC86 vectors for
yeast two-hybrid interaction studies; the prokaryotic expression vectors
pGEX-5X-2 (Amersham Pharmacia Biotech) and pET28c (Novagen) for
the production of GST- and His6-tagged fusion proteins; and the mam-
malian expression vectors pCDNA3.1() (Invitrogen) and pCHA (16)
for transfection into CHO and PC12 cells.
Protein Expression and Purification—GST or His6-tagged fusion pro-
teins were expressed in Escherichia coli BL21 cells as described previ-
ously (16). GST fusion proteins were affinity-purified by using the
glutathione-agarose beads (Sigma). His6-tagged proteins were purified
using the HisBind Resin and Buffer kit (Novagen). Protein concentra-
tions were estimated by Coomassie Blue staining of protein bands
following SDS-PAGE, using bovine serum albumin as standard.
Rat Brain GST Pull-down Assays—Rat brain extracts were prepared
by homogenizing the brains in a homogenization buffer (20 mM HEPES,
pH 7.4, 150 mM NaCl, 300 mM sucrose, plus protease inhibitors). Triton
X-100 was added to the homogenates to a final concentration of 1% and
incubated at 4 °C for 30 min. Insoluble material was removed by cen-
trifugation at 100,000  g for 1 h at 4 °C, and the supernatant was used
as the Triton X-100 extract of rat brains. For binding experiments, brain
extracts (100 l) were incubated at 4 °C for 1 h with various GST-Spring
fusion proteins immobilized on the glutathione-agarose beads. After ex-
tensive washes, bound proteins were eluted by boiling in the Laemmli
sample buffer and analyzed by SDS-PAGE and immunoblotting.
In Vitro Binding Assays—For binding experiments (Figs. 4A and 5A),
100 nM GST or various GST-SNARE fusion proteins immobilized on
glutathione-agarose beads were incubated with soluble His-Spring (50
nM) in the PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8
mM KH2PO4, pH 7.4 plus protease inhibitors) at 4 °C for 3 h under
gentle rocking. Bound proteins were analyzed by SDS-PAGE and im-
munoblotting. For saturation experiments (Fig. 4B), 100 nM immobi-
lized GST-SNAP-25 were incubated with increasing amounts of soluble
His-Spring or His-syntaxin 1 (residues 1–261) in the PBS buffer and
processed as above. The EC50 was defined as the effective concentration
of each soluble protein at half-maximal binding. For competition exper-
iments (Fig. 6, A and B), 50 nM immobilized GST-SNAP-25 were incu-
bated with a constant amount of His-Spring (50 nM) and increasing
amounts of His-syntaxin 1 or His-VAMP2. To study the effects of the
association of Spring with SNAP-25 on the ability of SNAP-25 to inter-
act with other SNAREs (Fig. 7, A–C), immobilized Spring-SNAP-25
binary complexes were assembled by incubation of 100 nM immobilized
GST-Spring with His-SNAP-25 (200 nM). After extensive washes to
remove unbound SNAP-25, the immobilized Spring-SNAP-25 com-
plexes were incubated with increasing amounts of His-Syntaxin 1,
His-VAMP2 or both His-Syntaxin 1 and His-VAMP2 (1:1 molar ratio) in
the PBS buffer and processed as above. Control binding experiments
were performed by incubation of immobilized GST-SNAP-25 (100 nM)
with His-Syntaxin 1, His-VAMP2 or both His-Syntaxin 1 and His-
VAMP2 (500 nM each).
Subcellular Fractionations—Subcellular fractionations of rat brain
into membrane and cytosol fractions were performed as described (16).
The membrane fractions were subjected to extraction by 4% Triton
X-100, 4 M urea, 1.5 M NaCl, or 100 mM Na2CO3, pH 11.5. For cytoskel-
eton association studies, rat brains were lysed in a cytoskeleton-stabi-
lizing buffer and separated into a low speed cytoskeleton fraction, a
high speed cytoskeleton fraction, and a soluble fraction according to a
standard procedure (18). For synaptosomal localization studies, rat
brain homogenates were fractionated into crude synaptosome fractions
as described (19). The washed crude synaptosome (P2) pellet fraction
was then fractionated on a three-step Percoll gradient into myelin,
mitochondria, and purified synaptosome fractions (20, 21). The purified
synaptosome fraction (PG3) was further fractionated into the synapto-
somal membranes (LP1), synaptic vesicle (LP2), and cytosol (LS2) frac-
tions (19). All protein samples were subjected to SDS-PAGE and
immunoblotting.
Coimmunoprecipitation—Extracts were prepared from CHO cells
transiently transfected with pCHA-Spring and pCDNA3.1-SNAP-25,
and immunoprecipitations were performed as described previously (22),
using rat monoclonal anti-HA antibody (3F10) or control rat IgG. For
detection of endogenous Spring-SNAP-25 complexes, the clarified su-
pernatant of solubilized P2 synaptosome fraction was subjected to
immunoprecipitation by anti-SNAP-25 antibody (SMI81) or control
mouse IgG. The immunocomplexes were recovered by incubation with
protein A/G-agarose beads (Santa Cruz Biotechnology) for 1 h at 4 °C.
After extensive washes, the immunocomplexes were analyzed by SDS-
PAGE and immunoblotting.
Cotransfection of PC12 Cells and Assays of GH Secretion—Exponen-
tially growing PC12 cells were harvested and then cotransfected with 5
g of pXGH5 encoding human growth hormone and 30 g of test
plasmid as described previously (16). Measurements of GH secretion
were performed 48 h after transfection. PC12 cells were washed with a
physiological salt solution (PSS (in mM): 145 NaCl, 5.6 KCl, 2.2 CaCl2,
0.5 MgCl2, 10 glucose, 15 HEPES, pH 7.4). The cells were then incu-
bated for 15 min at 37 °C in PSS or PSS containing 56 mM KCl and 95
mM NaCl. The amounts of GH released into the medium and retained in
the cells were determined by using a radioimmunoassay kit (Nichols
Institute).
RESULTS
Identification of Spring, a SNAP-25-Interacting RING Fin-
ger Protein—To identify novel proteins that regulate SNARE
function in neuronal cells, we used the full-length mouse
SNAP-25b as bait to screen a two-hybrid rat hippocampal/
cortical cDNA library. One of the positive clones was shown to
encode part of a novel protein that we referred to as Spring
because it is a SNAP-25-interacting RING finger protein. Re-
transformation experiments confirmed that Spring interacts
specifically with SNAP-25 but not with irrelevant baits such as
synaptophysin nor with other neuronal SNAREs such as syn-
taxin 1 and VAMP2 (data not shown; see Fig. 4A). Moreover,
our yeast two-hybrid interaction studies (not shown) and in
vitro binding data (Fig. 4A) reveal that, unlike several other
known SNAP-25-interacting proteins such as syntaxins, SNIP,
and intersectin, Spring does not interact with SNAP-23/syndet,
a ubiquitously expressed SNAP-25 homologue (23). Because
the t-SNARE coiled-coil domains of SNAP-25 share significant
homology with the t-SNARE domains in SNAP-23/syndet, syn-
taxin 1, and VAMP2 (24), the inability of Spring to interact
with these other SNARE proteins further confirms the speci-
ficity of observed Spring-SNAP-25 interaction.
By screening a ZAPII rat hippocampal cDNA library, we
isolated three full-length and nine independent overlapping
partial Spring cDNA clones. The full-length Spring cDNA con-
tains an in-frame stop codon upstream of the initiator ATG
codon with a Kozak consensus sequence and a single open
reading frame encoding 710 amino acids in length, with a
calculated molecular mass of 79.2 kDa (Fig. 1A). Spring is a
hydrophilic protein with a theoretical isoelectric point (pI) of
6.54 and a high percentage (22%) of charged amino acids over
the entire length. It contains neither a signal sequence nor a
potential transmembrane domain.
Analysis of Spring protein sequence reveals the presence of a
RING finger domain followed by two B box motifs and a coiled-
coil domain (Fig. 1), indicating that Spring is a new member of
the RING-B box coiled-coil (RBCC) subfamily of RING finger
proteins (25, 26). The RING finger and the B box motifs are
cysteine/histidine-rich Zn2-binding domains that are thought
to mediate protein-protein interactions (27). Although the func-
tion of the RBCC motif is unclear, this tripartite motif is found
in a growing number of proteins involved in diverse cellular
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processes, from gene transcription and signal transduction to
organelle transport (25, 26, 28). It has been proposed that the
RBCC motifs may act as molecular building blocks in formation
of large macromolecular scaffolds for these complex biological
processes (26). In addition to the RBCC motif, Spring contains
a fibronectin type III domain, an autonomously folded protein
module that is thought to mediate protein-protein interactions
in both intracellular and extracellular compartments (29). At
the C terminus, Spring has an SPRY domain, a putative pro-
tein-protein interaction module that was originally identified
in the spla kinase and the ryanodine receptor (30). The SPRY
domain has been found at the C terminus of several RBCC
proteins with a conserved spacing between these two domains
(31), although the significance of such a domain organization is
not understood.
Data base searches revealed the presence of Spring homo-
logues as uncharacterized cDNAs or open reading frames ob-
tained from genome projects in a number of organisms, includ-
ing human, mouse, Drosophila, Caenorhabditis elegans, and
zebrafish. The amino acid sequence of rat Spring is 98% iden-
tical to a recently published human sequence TRIM9, one of the
37 RBCC tripartite motif-containing proteins identified by
dbEST data base searches with a consensus of the B box do-
main (32). Moreover, the overall sequence of Spring protein
shares 41 and 47% identity with C. elegans hypothetical pro-
tein C39F7.2 (GenBankTM accession number T33778 and
AC006906) and a putative protein deduced from the genomic
sequence of Drosophila (a splice product of CG13145 and
CG6256 genes, GenBankTM accession number AE003629), re-
spectively (Fig. 1B). The conspicuous homology and conserved
domain structure among Spring homologues from different spe-
cies indicate that Spring is an evolutionarily conserved protein.
Brain-specific Expression of Spring mRNA and Protein—
Northern blot analysis of Spring mRNA expression revealed
the presence of a major Spring transcript of 5.6 kilobase pairs
and a minor form of 4.8 kilobase pairs, which may represent
the products of alternative splicing or differential polyadenyl-
ation (Fig. 2A). Spring mRNAs were prominently expressed in
rat brain but were undetectable in the other tissues examined.
Consistent with this result, analysis of human Spring mRNA
expression using a Multiple Tissue Expression Array showed
that Spring mRNA(s) was exclusively expressed in fetal and
adult human brain where it was widely distributed in all brain
regions tested (Fig. 2B).
FIG. 1. Structure of Spring. A, domain structure of Spring. Rat Spring is a 710-amino acid protein that contains an N-terminal RBCC tripartite
motif consisting of a RING finger, two B boxes, and a BBC domain, a fibronectin type III domain, and a C-terminal SPRY domain. Numbers indicate
the amino acid residues that define the boundaries of these domains. The location of the SNAP-25-interacting clone isolated from the yeast
two-hybrid screen (Y2H) is indicated below the domain structure. B, alignment of the rat Spring amino acid sequence with homologous proteins
deduced from the genomic sequences of Drosophila and C. elegans.
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To characterize Spring protein, a rabbit anti-Spring antibody
was generated against a 14-amino acid peptide of Spring. The
anti-Spring antibody, but not preimmune serum, specifically
recognized an 80-kDa protein in cells transfected with HA-
tagged, full-length Spring cDNA, whereas no immunoreactivity
was detected in vector-transfected control cells (Fig. 2C). The
same 80-kDa band was also detected using the anti-HA anti-
body (data not shown). In rat brain, the anti-Spring antibody
recognized a major 80-kDa band of endogenous Spring (Fig. 2,
C and D). Occasionally, some minor bands of lower molecular
weights were observed in brain homogenates as well as in cells
expressing recombinant Spring protein (Fig. 2, C and D). These
minor bands are likely to be the degradation products of the
Spring protein because their relative intensity as compared
with the 80-kDa band varied from preparation to preparation.
Pre-absorption of the anti-Spring antibody with recombinant
Spring protein completely eliminated its immunoreactivity to
both recombinant and endogenous Spring protein (data not
shown), confirming the specificity of the antibody. Western blot
analysis of multiple rat tissues showed that Spring was ex-
pressed exclusively in brain (Fig. 2D), which is consistent with
the pattern of Spring mRNA expression (Fig. 2A).
Subcellular Distribution of Spring in Brain—To determine
the intracellular distribution of Spring, rat brain postnuclear
supernatant was separated into cytosol and membrane partic-
ulate fractions and then subjected to Western blot analysis
with the anti-Spring antibody (Fig. 3A). Although the primary
structure of Spring does not contain any transmembrane do-
main, a large pool of Spring was found in the membrane frac-
tion. The membrane-associated Spring could be extracted by
1.5 M NaCl, 8 M urea, or a pH 11.5 solution, suggesting that it
is peripherally associated with membranes. Surprisingly, the
membrane-associated Spring was resistant to solubilization by
4% Triton X-100 (Fig. 3A), suggesting that it may be associated
with cytoskeleton. To examine this possibility, we used a well
established protocol to isolate directly the cytoskeleton frac-
tions from brain (18). The integrity of these fractions was
confirmed by immunoblotting with antibodies against actin,
synaptophysin, and SNAP-25 (Fig. 3B). Immunoblot analysis of
these fractions with the anti-Spring antibody revealed the
presence of a substantial amount of Spring in the cytoskeleton
fractions, indicating that a significant percentage of Spring is
associated with brain cytoskeleton.
To examine the subcellular distribution of Spring in more
detail, synaptosome fractions were isolated and further frac-
tionated using standard procedures (19–21). Spring was found
to copurify with synaptophysin and SNAP-25 in crude synap-
tosomes (fraction P2) as well as in the light membrane fraction
(P3) that contained a considerable percentage of synaptic ves-
icles and plasma membranes (Fig. 3C). Subsequent fraction-
ation of crude synaptosomes (P2) revealed that Spring was
enriched in purified synaptosomes (PG3), whereas no Spring
FIG. 2. Expression and distribution of Spring mRNA and protein. A, Northern blot analysis of Spring mRNA shows a high level of Spring
mRNA expression in rat brain. The loading of poly(A) RNA in each lane was confirmed by hybridization of the same blot with a 32P-labeled -actin
cDNA probe (lower panel). B, a Multiple Tissue Expression Array (CLONTECH) containing poly(A) RNA from various human tissues was
hybridized with a 32P-labeled Spring cDNA probe. The diagram of the RNA sources is shown on the right. C, specificity of the rabbit anti-Spring
antibody. Homogenates of rat brain and transfected CHO cells were analyzed by immunoblotting using the affinity-purified anti-Spring antibody.
D, Western blot analysis of Spring protein distribution. Equal amounts of homogenates (100 g of protein per lane) from the indicated rat tissues
were analyzed by immunoblotting using the anti-Spring antibody. Sk., skeletal.
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immunoreactivity was detected in the myelin (PG1) and mito-
chondria (PG4) fractions. To characterize further the distribu-
tion of Spring in synaptosomes, the purified synaptosome frac-
tion (PG3) was subfractionated into the synaptic plasma
membrane (LP1), synaptic vesicle (LP2), and cytosol (LS2) frac-
tions (Fig. 3C). As expected, synaptophysin was highly en-
riched in the synaptic vesicle fraction, whereas SNAP-25 was
found primarily in the synaptic plasma membrane fraction and
to a lesser extent in the synaptic vesicle fraction (33). Spring
was co-enriched with synaptophysin in the synaptic vesicle
fraction. In addition, Spring was present in the synaptosomal
cytosol fraction but was absent in the synaptic plasma mem-
brane fraction. Together, these data suggest that Spring is
enriched at synaptic terminals where it exists in a soluble form
and a synaptic vesicle-associated form.
Direct and Specific Association of Spring with SNAP-25—To
determine whether the Spring-SNAP-25 interaction detected
in yeast actually takes place in vitro, we performed in vitro
binding assays using recombinant proteins. As shown in Fig.
4A, His-tagged Spring bound selectively to GST-SNAP-25 but
not to GST alone or other SNARE proteins, such as SNAP-23/
syndet, syntaxin 1, and VAMP2. These in vitro binding data
demonstrate a direct and specific association between Spring
and SNAP-25, which is consistent with the result of yeast
two-hybrid interaction analysis. To further characterize bio-
chemically the interaction between Spring and SNAP-25, a
series of in vitro binding assays were performed by incubation
of increasing concentrations of soluble Spring with immobilized
GST-SNAP-25 (Fig. 4B). The results showed that Spring bound
to GST-SNAP-25 in a dose-dependent and saturable manner,
with an EC50 (the effective concentration at half-maximal bind-
ing) of approximate 20 nM Spring. As a control, we analyzed the
in vitro binding of syntaxin 1 to GST-SNAP-25 in parallel
experiments (data not shown). Under the same experimental
conditions, syntaxin 1 bound to SNAP-25 with an EC50 of 400
nM syntaxin 1. Thus, Spring seems to bind SNAP-25 with
higher apparent affinity than syntaxin 1. Furthermore, the
complex formed between Spring and SNAP-25 has a stoichiom-
etry of 1:1, as determined by scanning of Coomassie Blue-
stained gels and by comparison with the titration curves of
recombinant Spring and SNAP-25 (data not shown but see
Fig. 7).
The strong interaction between Spring and SNAP-25 ob-
served in vitro suggests that these two proteins may associate
with each other in vivo. To examine this possibility, we first
performed coimmunoprecipitation experiments using lysates of
CHO cells cotransfected with SNAP-25 and HA-tagged Spring
(Fig. 4C). Spring and SNAP-25 were coimmunoprecipitated by
the anti-HA antibody but not by the IgG control, confirming a
specific association of Spring with SNAP-25 in mammalian
cells. We then performed additional coimmunoprecipitation ex-
periments to examine the association of endogenous Spring and
SNAP-25 in rat brain synaptosomes (Fig. 4D). Anti-SNAP-25
antibody, but not the mouse IgG control, was able to coimmu-
noprecipitate SNAP-25 and Spring from solubilized synapto-
somes, indicating the existence of endogenous Spring-SNAP-25
complexes.
Identification of the Binding Domains of SNAP-25 and
Spring—To understand the structural requirements that un-
derlie the interaction between Spring and SNAP-25, we used
deletion analysis to map the specific domains of SNAP-25 and
Spring required for their association. A series of SNAP-25
deletion mutants were generated as GST fusion proteins and
tested for their ability to bind recombinant Spring in the in
vitro binding assays (Fig. 5A). The results demonstrated that
only the fusion proteins containing the N-terminal t-SNARE
domain (SNAP-251 to SNAP-253) were capable of binding
Spring, whereas the C-terminal t-SNARE domain and the cen-
tral domain of SNAP-25 were not required for the binding. The
entire N-terminal t-SNARE domain (SNAP-253) was both
necessary and sufficient for binding Spring, because further
truncations of this domain (SNAP-257 or SNAP-258) abol-
ished its ability to bind Spring.
To delineate the region of Spring involved in binding SNAP-
25, we generated a series of GST fusion proteins containing
various truncations of Spring, and we analyzed their interac-
tion with endogenous SNAP-25 in rat brain extracts (Fig. 5B).
The B box C-terminal coiled-coil (BBC) domain of Spring was
found to be solely responsible for binding SNAP-25, whereas
the RING finger, two B box domains, and the C-terminal fi-
bronectin type III and SPRY domains were not involved. These
results, together with those of Fig. 5A, demonstrate that the
association of Spring with SNAP-25 is mediated by the BBC
domain of Spring and the N-terminal t-SNARE domain of
SNAP-25.
Spring Competes with Syntaxin 1 and VAMP2 for Binding to
SNAP-25—Previous studies (34, 35) have shown that the
N-terminal t-SNARE coiled-coil domain of SNAP-25 directly
binds syntaxin 1, whereas both N- and C-terminal t-SNARE
domains are required for binding VAMP2. Thus, the binding of
Spring to the N-terminal t-SNARE domain of SNAP-25 may
affect the binding of syntaxin 1 and/or VAMP2 to SNAP-25. To
test these possibilities, we performed a series of in vitro binding
experiments by incubation of immobilized GST-SNAP-25 with
a constant amount of Spring and increasing amounts of syn-
taxin 1 (Fig. 6A). The results showed that as the concentration
of syntaxin 1 increased, the binding of Spring to SNAP-25
FIG. 3. Subcellular distribution of Spring in brain. A, post-
nuclear supernatant (T) from rat brain was separated into cytosol (C)
and membrane (M) fractions. The membranes were then extracted with
1.5 M NaCl, 4% Triton X-100 (TX-100), 0.1 M Na2CO3, pH 11.5, or 4 M
urea, and separated into soluble (S) and pellet (P) fractions. Aliquots
representing an equal percentage of each fraction were analyzed by
immunoblotting. B, total lysate (T) from rat brain was separated into a
low speed cytoskeleton fraction (L), a high speed cytoskeleton fraction
(H), and a soluble fraction (S). Aliquots representing an equal percent-
age of each fraction were analyzed by immunoblotting. C, rat brain
homogenates were fractionated as described under “Experimental Pro-
cedures.” The fractions are as follows: H, homogenate; S1, 800  g
supernatant; P1, 800  g pellet; S2, 9,200  g supernatant; P2 (crude
synaptosomes), 9,200  g pellet; S2, 10,200  g supernatant; P2
(washed synaptosomes), 10,200  g pellet; C (cytosol), 165,000  g
supernatant; P3 (light membranes), 165,000  g pellet; PG1, myelin
fraction; PG2, myelin-synaptosome fraction; PG3, purified synaptosome
fraction; PG4, mitochondria fraction; LS1, 25,000  g supernatant of
lysed PG3 synaptosomes; LP1 (synaptic plasma membranes), 25,000 
g pellet; LS2 (cytosolic synaptosomal fraction), 165,000  g superna-
tant; LP2 (crude synaptic vesicles), 165,000  g pellet. Equal amounts
of proteins from each fraction were analyzed by immunoblotting.
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diminished gradually, indicating that Spring and syntaxin 1
compete with each other for binding to SNAP-25. Similarly,
when immobilized GST-SNAP-25 was incubated with a con-
stant amount of Spring and increasing amounts of VAMP2,
Spring and VAMP2 were found to bind to SNAP-25 in a com-
petitive manner (Fig. 6B).
Association of Spring with SNAP-25 Inhibits the Assembly of
SNARE Complexes—Because the N- and C-terminal t-SNARE
domains of SNAP-25 are directly involved in formation of bi-
nary and ternary SNARE complexes, the binding of Spring to
the N-terminal t-SNARE domain of SNAP-25 is likely to inter-
fere with assembly of these SANRE complexes. To examine the
effect of the association of Spring with SNAP-25 on the assem-
bly of the binary SNAP-25-syntaxin 1 complex, immobilized
GST-Spring was preincubated with soluble SNAP-25 to form
binary Spring-SNAP-25 complexes. After extensive washes to
remove unbound SNAP-25, the ability of the immobilized bi-
nary Spring-SNAP-25 complexes to bind syntaxin 1 was tested
in a series of in vitro binding reactions with increasing concen-
trations of syntaxin 1 (Fig. 7A). The results demonstrated that
the association of Spring with SNAP-25 was able to prevent the
interaction of SNAP-25 with syntaxin 1. Conversely, when
immobilized binary SNAP-25-syntaxin 1 complexes were incu-
bated with increasing concentrations of Spring, no detectable
binding of Spring to the SNAP-25-syntaxin 1 complexes was
observed (data not shown). Thus, the association of SNAP-25
with Spring and the association of SNAP-25 with syntaxin 1
are mutually exclusive.
We also performed a similar series of binding experiments to
examine the relationship between the association of SNAP-25
with Spring and the interaction of SNAP-25 with VAMP2. The
association of Spring with SNAP-25 was found to abolish the
ability of SNAP-25 to interact with VAMP2 (Fig. 7B). To fur-
ther test whether the Spring/SNAP-25 interaction interferes
with the ability of SNAP-25 to form the ternary SNARE com-
plex, in vitro binding experiments were carried out by incuba-
tion of immobilized Spring-SNAP-25 complexes with increasing
concentrations of both syntaxin 1 and VAMP2 (Fig. 7C). The
results demonstrated that the association of Spring with
SNAP-25 completely prevented the assembly of the ternary
SNARE complex.
Role of Spring in Ca2-dependent Exocytosis—To determine
whether Spring is involved in Ca2-dependent exocytosis, we
investigated the effect of overexpression of Spring and its frag-
ments on the regulated secretion of growth hormone (GH) from
PC12 cells using a GH cotransfection secretion assay (36). This
assay uses human GH expressed from the cotransfected plas-
mid as a reporter for regulated exocytosis and has been widely
used for functional studies of presynaptic proteins (37, 38). The
expressed GH is stored in dense core vesicles of the transfected
PC12 cells and undergoes Ca2-dependent exocytosis in re-
sponse to depolarization by high K (39). To examine the effect
of Spring on GH secretion, various Spring cDNA constructs
were cotransfected with the pXGH5 encoding human GH. As a
positive control, the cytoplasmic region of syntaxin 1 (residues
1–261) was cotransfected in parallel experiments. Western blot
analysis of cell lysates confirmed that exogenous Spring pro-
teins and syntaxin 1 were expressed at similar levels in trans-
fected cells (Fig. 8A). Analysis of GH secretion revealed that
overexpression of full-length Spring or a truncated form
(Spring7) of Spring containing the SNAP-25-interacting do-
main (residues 267–408) resulted in a large decrease in the
FIG. 4. Specific interaction of Spring with SNAP-25. A, soluble His-tagged Spring proteins (50 nM) were incubated with 100 nM immobilized
GST or GST fusion proteins (lower panel, Ponceau S staining). Bound Spring was detected by immunoblotting (upper panel). B, immobilized
GST-SNAP-25 fusion proteins (100 nM) were incubated with increasing concentrations of soluble Spring as indicated. Quantification of the amount
of bound Spring demonstrates that Spring binds to GST-SNAP-25 in a dose-dependent and saturable manner. C, coimmunoprecipitation of Spring
with SNAP-25 from transfected CHO cells. Extracts from CHO cells cotransfected with pCHA-Spring and pcDNA3.1-SNAP-25 were subjected to
immunoprecipitation with anti-HA antibody (3F10) or control rat IgG. D, association of endogenous Spring with SNAP-25 in rat brain. Detergent
extracts of rat synaptosomes (P2 fractions) were subjected to immunoprecipitation with anti-SNAP-25 antibody or control mouse IgG. The
immunoprecipitates in C and D were analyzed by immunoblotting for Spring and SNAP-25.
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high K-induced GH release (Fig. 8B), whereas the basal GH
release was not affected (data not shown). The extent of reduc-
tion in the stimulated GH secretion was comparable with that
caused by overexpression of the cytoplasmic region of syntaxin
1 (Fig. 8B) (37, 38). In contrast, overexpression of Spring2, a
fragment of Spring (residues 1–138) that is unable to bind
SNAP-25 (Fig. 5B), did not have any significant effect on basal
GH release nor on stimulated GH release (Fig. 8B). Together,
these data suggest that Spring has a functional role in modu-
lating Ca2-dependent exocytosis through its binding to
SNAP-25.
DISCUSSION
In this study, we have identified and characterized Spring, a
novel RING finger protein that interacts with SNAP-25, an
essential component of neurotransmitter release machinery.
Spring is exclusively expressed in brain and is concentrated at
synapses. Spring interacts specifically with SNAP-25 but not
with other SNAREs such as syntaxin 1 and VAMP2. Further-
more, unlike some other SNAP-25-binding partners such as
syntaxins, SNIP, and intersectin, Spring does not interact with
SNAP-23, a ubiquitously expressed isoform with 65% identity
to SNAP-25, indicating that the interaction between Spring
and SNAP-25 is highly specific. Moreover, Spring and SNAP-25
form a high affinity, stoichiometric complex that is unable to
associate with syntaxin 1 and VAMP2 to form the SNARE
fusion complex. The synaptic localization and binding proper-
ties of Spring suggest that Spring is well positioned to modu-
late synaptic vesicle exocytosis. Consistent with this notion,
overexpression of full-length Spring or its SNAP-25-interacting
domain leads to a significant inhibition of Ca2-dependent
exocytosis from PC12 cells.
Our data support a model in which Spring, by interacting
with monomeric SNAP-25, serves as a regulator of synaptic
vesicle exocytosis. The association of Spring with the N-termi-
nal t-SNARE domain of SNAP-25 may keep SNAP-25 in an
FIG. 5. Identification of interacting domains of SNAP-25 and Spring. A, mapping of the Spring binding domain of SNAP-25. Schematic
representation of SNAP-25 and its deletion mutants encoded by the GST fusion cDNA constructs is shown on the top. These fusion proteins were
immobilized on glutathione-agarose beads (lower panel, Ponceau S staining) and incubated with His-Spring. Bound Spring was detected by
immunoblotting. B, mapping of the SNAP-25-binding domain of Spring. Rat brain homogenate (Input) was incubated with immobilized GST fusion
proteins containing full-length or truncated forms of Spring as indicated. Bound SNAP-25 was detected by immunoblotting, and GST-Spring fusion
proteins were shown as Ponceau S staining.
FIG. 6. Spring competes with syntaxin 1 and VAMP2 for bind-
ing to SNAP-25. A, binding competition between Spring and syntaxin
1 to SNAP-25. Immobilized GST-SNAP-25 (50 nM) was incubated with
a constant amount of His-Spring (50 nM) and increasing amounts of
His-syntaxin 1. Bound Spring and syntaxin 1 were detected by immu-
noblotting, and GST-SNAP-25 was shown as Ponceau S staining. B,
binding competition between Spring and VAMP2 to SNAP-25. Immobi-
lized GST-SNAP-25 (50 nM) was incubated with a constant amount of
His-Spring (50 nM) and increasing amounts of His-VAMP. Bound
Spring and VAMP2 were detected by immunoblotting, and GST-
SNAP-25 was shown as Ponceau S staining.
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inactive state, unavailable to interact with other components of
the SNARE fusion machinery. The binding characteristic of
Spring to SNAP-25 is reminiscent of the binding of nSec1 (also
known as Munc-18) to syntaxin 1, which makes syntaxin 1
inaccessible for interacting with other SNAREs to form the
SNARE fusion complex (38, 40). Although based on these bind-
ing properties one would predict that nSec1 should negatively
regulate vesicle exocytosis, accumulating evidence indicates
that nSec1 plays both a positive and negative role in neuro-
transmitter release (41–43). Similarly, it is possible that
Spring may also have dual functions in synaptic vesicle exocy-
tosis. For example, the association of the cytosolic form of
Spring with SNAP-25 localized on the plasma membrane may
interfere with the formation of trans-SNARE complexes, thus
negatively regulating synaptic vesicle fusion. On the other
hand, the synaptic vesicle-associated form of Spring may be
involved in sequestering vesicular SNAP-25 after it has been
dissociated from cis-SNARE complexes by N-ethylmaleimide-
sensitive factor in conjunction with soluble N-ethylmaleimide-
sensitive factor attachment protein (SNAP) (44). This seques-
tration of vesicular SNAP-25 monomers would prevent
reformation of cis-SNARE complexes on synaptic vesicles,
thereby favoring the formation of trans-SNARE complexes and
having a positive role in synaptic vesicle exocytosis.
The apparent affinity (EC50) of Spring binding to SNAP-25
(Fig. 4B) is more than 20-fold higher than that of syntaxin 1 to
SNAP-25 and more than 300-fold higher than that of VAMP2 to
SNAP-25 (45, 46). Moreover, the complex formed between
Spring and SNAP-25 is so stable that syntaxin 1 and VAMP2
are unable to dissociate SNAP-25 from the complex (Fig. 7,
A–C). These findings suggest that the transition of SNAP-25
from a Spring-bound state to a SNARE (syntaxin 1 and
VAMP2)-associated state is highly regulated. This regulation is
unlikely to be mediated directly by a rise in intracellular Ca2
concentration that triggers vesicle fusion, as our binding stud-
ies show that the interaction between Spring and SNAP-25 is
insensitive to Ca2 over a wide range (0–1 mM) of free Ca2
concentrations (data not shown). Instead, this transition prob-
ably involves the regulation by protein phosphorylation. It has
been proposed that phosphorylation of nSec1/Munc-18 by pro-
tein kinase C inhibits its association with syntaxin 1, thus
facilitating the SNARE complex formation and synaptic vesicle
fusion (47, 48). A similar mechanism may be involved in regu-
FIG. 7. Association of Spring with SNAP-25 abolishes the abil-
ity of SNAP-25 to interact with other SNAREs. A, the association
of Spring with SNAP-25 prevents the interaction of SNAP-25 with
syntaxin 1. Immobilized Spring-SNAP-25 binary complexes were as-
sembled by incubation of GST-Spring (100 nM) with His-SNAP-25 (200
nM). After extensive washes, the immobilized Spring-SNAP-25 com-
plexes (shown as Ponceau S staining) were incubated with increasing
amounts of His-Syntaxin 1. Bound syntaxin 1 was detected by immu-
noblotting. In the control lane, a parallel binding experiment was per-
formed by incubation of immobilized SNAP-25 (100 nM) with 500 nM
His-Syntaxin 1. B, the association of Spring with SNAP-25 prevents the
interaction of SNAP-25 with VAMP2. Immobilized Spring-SNAP-25
binary complexes (shown as Ponceau S staining) were assembled as
described in A and then incubated with increasing amounts of His-
VAMP2. Bound VAMP2 was detected by immunoblotting. In the control
lane, a parallel binding experiment was performed by incubation of
immobilized SNAP-25 (100 nM) with 500 nM His-VAMP2. C, the asso-
ciation of Spring with SNAP-25 prevents the assembly of the ternary
SNARE complex. Immobilized Spring-SNAP-25 binary complexes
(shown as Ponceau S staining) were assembled as described in A and
then incubated with increasing amounts of His-syntaxin 1 and His-
VAMP2 (1:1 molar ratio). Bound syntaxin 1 and VAMP2 were detected
by immunoblotting. In the control lane, a parallel binding experiment
was performed by incubation of immobilized SNAP-25 (100 nM) with
His-syntaxin 1 and His-VAMP2 (500 nM each).
FIG. 8. Effect of overexpression of Spring and its fragments on
Ca2-dependent exocytosis from PC12 cells. A, PC12 cells were
cotransfected with pXGH5 encoding human GH and a test plasmid as
indicated: lane 1, pCHA; lane 2, pCHA-syntaxin 1; lane 3, pCHA-
Spring; lane 4, pCHA-Spring7; and lane 5, pCHA-Spring2. Cells
were then lysed, and equal amounts of protein from each lysate (100 g
of protein per lane) were analyzed by sequential immunoblotting with
anti-HA, anti-actin, and anti-SNAP-25 antibodies. B, the K-stimu-
lated GH secretion was determined from PC12 cells transfected as
described in A and expressed as a percentage of total GH content. Data
are means  S.E. (error bars) of the results from three independent
determinations.
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lating the interaction of Spring with SNAP-25. Consistent with
this possibility, the sequence of Spring contains multiple con-
sensus serine/threonine phosphorylation sites (9 sites for pro-
tein kinase C, 3 sites for cAMP-dependent protein kinase/pro-
tein kinase G, and 5 sites for Ca2/calmodulin-dependent
protein kinase II) and 9 predicted tyrosine phosphorylation
sites (49, 50). Phosphorylation of one or several of these sites
may lead to the dissociation of SNAP-25 from Spring, thereby
allowing SNAP-25 to interact with other components of the
SNARE fusion machinery to facilitate synaptic vesicle exocytosis.
It is becoming increasingly clear that the function of synaptic
SNAREs is regulated by other proteins, perhaps as a means to
control the temporal and spatial formation of the SNARE fu-
sion complexes. For example, more than a dozen regulators of
syntaxin 1 have been identified, including nSec1/Munc-18,
Munc-13, complexins, CIRL/latrophilin, tomosyn, and syn-
taphilin (37, 51–56). In comparison, the list of SNAP-25 regu-
lators is fairly short. The present work has identified Spring as
a potential neuron-specific regulator of SNAP-25. Interest-
ingly, unlike nSec1 (a neuronal homologue of yeast Sec1 pro-
tein), Spring does not appear to have a yeast homologue, al-
though there are Spring homologues in Drosophila, C. elegans,
and zebrafish. In fact, despite a high degree of conservation
from yeast to man in the basic components of the fusion ma-
chinery such as SNAREs, Rabs, and Sec1s, there is no evidence
for the presence in yeast of a number of regulators of synaptic
vesicle exocytosis, such as complexin, Munc-13, and synapsin.
These neuron-specific proteins may have evolved to exert ad-
ditional layers of regulation on neurotransmitter release, a
highly specialized form of vesicular trafficking in multicellular
organisms.
Spring is a novel member of the growing RING finger family.
The RING finger is a cysteine/histidine-rich Zn2-binding mo-
tif that is found in a number of proteins involved in diverse
cellular processes (25, 26). Although no unifying role has been
identified for the RING function, the emerging common theme
is that RING fingers appear to mediate the formation and
architecture of large protein complexes that are critical for
these cellular processes (25, 26). In addition to the RING finger,
Spring contains other protein-protein interaction motifs,
namely two Zn2-binding B boxes, a coiled-coil domain, a fi-
bronectin type III domain, and a SPRY domain. Thus, Spring
could potentially interact with multiple proteins or participate
in the formation of multiprotein complexes. The RING finger,
two B boxes, and the coiled-coil domain of Spring form a tri-
partite RBCC motif, whose domain organization is evolution-
arily conserved. The RBCC motif has been found in a variety of
proteins, some of which have been implicated in vesicular traf-
ficking such as ARD1 (57) and BERP (28). It has been proposed
that the RBCC motif may play a scaffolding role via homo-
oligomerization and interactions with other proteins (25, 26).
Our immunoprecipitation studies of HA- and FLAG-tagged
Spring proteins revealed that Spring associates with itself to
form homo-oligomers (data not shown). Furthermore, the
RBCC motif in several proteins, such as MID1 and BERP, has
been shown to interact with cytoskeletal elements, such as
microtubules and actinin-4 (58, 59). In this study, we have
shown that a significant pool of Spring is associated with brain
cytoskeleton fractions (Fig. 3B). Together, these findings sug-
gest that Spring may be involved in the formation of a multi-
protein complex with cytoskeletal proteins, SNAP-25, and
other proteins to regulate synaptic vesicle docking and fusion.
Interestingly, two yeast RING finger proteins, Vps11 and
Vps18, have recently been shown to form a multiprotein com-
plex called the C-Vps complex with Vps33 (a Sec1 homologue),
Vps16, Vps39, and Vps41 (60, 61). The C-Vps complex seems to
direct the following three distinct reactions: activating Ypt7 (a
rab GTPase), tethering vesicles to the vacuole, and interacting
with unpaired/activated Vam3 (a t-SNARE) to facilitate the
formation of the SNARE fusion machinery. By orchestrating
these reactions, the RING finger C-Vps complex plays a key
role to ensure the specificity and efficiency of the vacuole fusion
process (61). Future studies will determine whether Spring
forms a functionally similar multiprotein complex at nerve
terminals to coordinate various protein-protein interactions
important in synaptic vesicle docking and fusion.
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